Anti-Infective Drugs Advisory Committee
January 30, 2001
NDA 50-755 Augmentin (amoxicillin/clavulantate potassium)
Food and Drug Administration
Briefing Information doc pdf
The statements contained in this document are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.